Snipd home pageGet the app
public
The David Rubenstein Show chevron_right

Anne Wojcicki

Aug 11, 2022
24:30
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
1
Introduction
00:00 • 4min
chevron_right
2
The Future of Genetic Health Care With 23andMe
04:02 • 2min
chevron_right
3
What Are the Biggest Surprises for People With Alzheimer's?
06:20 • 2min
chevron_right
4
23andme
08:21 • 3min
chevron_right
5
The Digital Mindset - A New Podcast
11:28 • 5min
chevron_right
6
What I Love About 23andMe
16:10 • 3min
chevron_right
7
Is There a Higher Calling Than Working for Hedge Funds?
18:58 • 2min
chevron_right
8
Genetic Information Is Not Adoptable in Primary Care
20:38 • 4min
chevron_right
9
The World Is Increasingly Digital - This Is Digital
24:44 • 5min
chevron_right
10
23andMe - How Do You Think You're Making a Difference?
30:07 • 2min
chevron_right
11
Going Public
32:00 • 2min
chevron_right
12
23andMe Therapeutics
34:07 • 2min
chevron_right
13
Why I Love 23andMe
35:43 • 2min
chevron_right
14
Are You Giving Me My Job Offer?
37:49 • 6min
chevron_right

Anne Wojcicki, 23andMe CEO and co-founder, talks about surprising customers, the importance of genomics and going public with help from Richard Branson. She's on "The David Rubenstein Show: Peer-to-Peer Conversations." This was recorded July 21 in Palo Alto.

See omnystudio.com/listener for privacy information.

HomeTop podcastsPopular guests